Exagen Inc. (NASDAQ: XGN)
$4.2500
+0.3300 ( +7.60% ) 62.3K
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Market Data
Open
$4.2500
Previous close
$3.9200
Volume
62.3K
Market cap
$73.68M
Day range
$3.7120 - $4.3100
52 week range
$1.3003 - $4.8300
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 14, 2024 |
3 | Insider transactions | 2 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
8-k | 8K-related | 13 | Jun 11, 2024 |
4 | Insider transactions | 1 | May 16, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 61 | May 13, 2024 |